News

Biotech's Boom Suffers a Setback in March April 01, 2014 | Press Release

Investors Flock to Biotech March 03, 2014 | Press Release

Biotech IPOs Off to a Strong Start in 2014 February 03, 2014 | Press Release

  See all News
 
Sign up for a free subscription to The Burrill Weekly Brief 
Sign up to receive email notifications about our upcoming events and news.



Stephen A. Hurly

CEO, Burrill Securities

Stephen A. Hurly joined Burrill Securities as its CEO in June 2011. He brings an expertise in assisting public and private firms with strategic transactions, difficult financings, product licensing, joint ventures and restructurings. He has experience at both bulge bracket firms as well as specialized boutiques. Through extensive industry relationships and global transaction experience in China, Japan, Australia, the European Union, and North America, Mr. Hurly and his team provide tailored solutions and insight to assist clients in reaching their strategic goals.

Mr. Hurly has previously worked at Hambrecht & Quist in San Francisco, and UBS in New York City. He is an expert in strategic transactions and difficult public and private capital raising. He has completed more than 100 transactions with an aggregate value of more than $10 billion and more than $400 million in capital raised. He has an M.B.A. from the University of Chicago and a B.S. in Engineering from Swarthmore College.